News
Instead of high marketing spends or rapid category expansion, Fixderma is doubling down on dermatology-led products and ...
Zion Health welcomes Taylor Francesconi as Sales Manager to lead growth, retail partnerships, and clean product innovation rooted in ionic clay minerals. Haim Zion Zion Health Inc. +1 9164794018 email ...
Following a suspension of its NOM certification, PATRÓN doubles down on ingredient transparency with a bold U.S. push that ...
Achieves critical regulatory milestones, positioning company as leading turnkey partner in booming hypochlorous acid sector to capture portion of gro ...
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
16h
Sourcing Journal on MSNThe Science of SunwearThe Skin Cancer Foundation's seal of recommendation for sun-protective clothing got an upgrade. Certified brands weighed in ...
This week, our top stories include innovative ways to decarbonise cement manufacturing, JLR's tyre transformation and AI ...
Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...
23hon MSNOpinion
What are the measurable ‘quantifiable’ successes of the China-Africa Cooperation? How doChina-Africa cooperation parties ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results